article thumbnail

Simple test for flu could improve diagnosis and surveillance

Broad Institute

Simple test for flu could improve diagnosis and surveillance By Allessandra DiCorato June 18, 2024 Breadcrumb Home Simple test for flu could improve diagnosis and surveillance A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.

Virus 144
article thumbnail

COVID-19 patients are experiencing long-term effects from the virus

The Pharma Data

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study. A further 21% of 1,030 doctors who had since recovered from the virus reported chronic fatigue, while 11% said they had no concentration difficulties. Photo by Mohsen Atayi. Conor Kavanagh. Source link.

Virus 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A third of UK doctors have treated COVID-19 patients without full PPE, report finds

The Pharma Data

Report also highlights the impact of COVID-19 on the physical and mental health of doctors. A new report has found that more than a third of UK doctors have treated COVID-19 patients in person without sufficient personal protective equipment (PPE) during the pandemic. Source link.

Doctors 52
article thumbnail

Can a heartburn drug help doctors treat COVID-19?

The Pharma Data

In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. But in more severe illnesses, cytokine production can spiral out of control, becoming dysregulated.

Doctors 52
article thumbnail

Women in STEM with Delphine Guyon-Gellin

Drug Target Review

She holds a Doctorate from the Ecole Vétérinaire de Maisons-Alfort and a Master’s degree in Marketing from the HEC Paris. DGG: At Osivax, we’re working on a new class of vaccines that target invariant parts of mutating viruses; this approach is disruptive and very different from conventional vaccines.

Vaccine 110
article thumbnail

Coronavirus doctor's diary: Trying out tech that may help make worship Covid-secure

The Pharma Data

He picked up the virus right at the start of the pandemic and had a relentless and gruelling illness followed by a lingering debilitation that has lasted over six months. Or read the previous online diary entry: Will universities be able to avoid spreading the virus? Front line diary. Image copyright. Ian Beesley.

Doctors 52
article thumbnail

Battling antibiotic resistance in the lab and the clinic

Broad Institute

He has also emerged in recent years as a skilled and relatable science communicator, renowned for his efforts at Broad and beyond during the COVID-19 pandemic to unpack the fast-moving research on the new virus in an accessible way and give practical advice about masking, vaccines, and other public health measures.

Hospitals 137